Objective To evaluate the damage to retinal function in patients receiving hydroxychloroquine (HCQ) by observing the changes in the retinal nerve fiber layer (RNFL). Methods A retrospective study was performed on 30 patients with rheumatoid arthritis who were treated with HCQ therapy and 30 healthy people. Visual acuity, visual field and fundus examinations as well as optical coherence tomography (OCT) were compared between the two groups. Results Visual acuity, visual field and fundus examinations were normal. Decreases were noted with OCT. Conclusion OCT can detect early retinal toxicity due to hydroxychloroquine.
胡赛静,毛崇溶. 应用OCT观察羟氯喹对视网膜的早期影响[J]. 中华眼视光学与视觉科学杂志, 2015, 17(3): 181-183.
Hu Saijing,Mao Chongrong. Effect of hydroxychloroquine treatment on the retinal nerve fiber layer. Chinese Journal of Optometry Ophthalmology and Visual science, 2015, 17(3): 181-183. DOI: 10.3760/cma.j.issn.1674-845X.2015.03.012
Hess DB, Asrani SG, Bhide MG, et al. Macular and retinal nerve fiber layer analysis of normal and glaucomatous eyes in children using optical coherence tomography[J]. Am J Ophthalmol,2005,139(3):509-517.
[2]
Hood DC, Raza AS. Method for comparing visual field defect stolocal RNFL and RGC damage seen on frequency domain OCT in patients with glancoma[J]. Biomed Opt Express,2011, 2(5):1097-1105.
[3]
Garas A, Vargha P, Holló G. Diagnostic accuracy of nerve fibre layer macular thickness and optic disc measurements made with the RTVue-100 optical coherence tomograph to detect glaucoma[J]. Eye (Lond),2011,25(1):57-65.
Vizzeri G, Weinreb RN, Gonzalez-Garcia AO, et al. Agreement between spectral-domain and time-domain OCT for measuring RNFL thickness[J]. Br J Ophthalmol,2009,93(6):775-781.
[6]
Tehrani R, Ostrowski RA, Hariman R, et al. Ocular toxicity of hydroxychloroquine[J]. Semin Ophthalmol,2008,23(3):201-209.
[7]
Ingster-Moati I, Bui Quoc E, Crochet M, et al. Severe chloroquine- and hydroxychloroquine-induced retinopathy[J]. J Fr Ophtalmol,2006,29(6):642-650.
Blomquist PH, Chundru RK. Screening for hydroxychloroquine toxicity by Texas ophthalmologists[J]. J Rheum,2002,29(8):1665-1670.
[14]
Marmor MF. The dilemma of hydroxychloroquine screening: new information from the multifocal ERG[J]. Am J Ophthalmol,2005, 140(5):894-895.
[15]
Marmor MF, Carr RE, Easterbrook M, et al. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology[J]. Ophthalmology,2002,109(7):1377-1382.
[16]
Lai TY, Chan WM, Li H, et al. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy[J]. Am J Ophthalmol,2005,140(5):794-807.